Cargando…
Integration of Proteomics, Bioinformatics, and Systems Biology in Traumatic Brain Injury Biomarker Discovery
Traumatic brain injury (TBI) is a major medical crisis without any FDA-approved pharmacological therapies that have been demonstrated to improve functional outcomes. It has been argued that discovery of disease-relevant biomarkers might help to guide successful clinical trials for TBI. Major advance...
Autores principales: | Guingab-Cagmat, J.D., Cagmat, E.B., Hayes, R.L., Anagli, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668328/ https://www.ncbi.nlm.nih.gov/pubmed/23750150 http://dx.doi.org/10.3389/fneur.2013.00061 |
Ejemplares similares
-
Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats
por: Kobeissy, Firas H., et al.
Publicado: (2016) -
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
por: Stockard, Bradley, et al.
Publicado: (2018) -
Re-modeling of foliar membrane lipids in a seagrass allows for growth in phosphorus-deplete conditions
por: Koelmel, Jeremy P., et al.
Publicado: (2019) -
Metabolomics Insights into Chemical Convergence in Xanthomonas perforans and Metabolic Changes Following Treatment with the Small Molecule Carvacrol
por: Jibrin, Mustafa Ojonuba, et al.
Publicado: (2021) -
Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML
por: Stockard, Bradley, et al.
Publicado: (2021)